CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- 4 Option exercise President and CEO acquired 5,000 shares (option exercise)
- EFFECT Other Notice of Effectiveness
- 4 Open-market sale President and CEO sold 5,000 shares at $16.02 ($80,100)
- POS AM Other Post-effective Amendment for Registration Statement
- 4 Open-market sale President and CEO sold 5,000 shares at $15.99 ($79,950)
- 4 Open-market buy Principal Financial Officer bought 650 shares at $15.73 ($10,225)
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 5,000 shares at $15.45 ($77,250)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 424B3 Offering Prospectus
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
Page 45 of 68 · 1,358 filings